Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Dopamine,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Piramal Critical Care
Deal Size : Inapplicable
Deal Type : Inapplicable
BrePco Biopharma and Piramal Critical Care Announce MHRA Approval for Neoatricon in UK
Details : Neoatricon (dopamine hydrochloride) is a Beta-1 adrenergic receptor stimulator, small molecule drug candidate, which is indicated for the treatment of hypotension.
Product Name : Neoatricon
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 21, 2025
Lead Product(s) : Dopamine,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Piramal Critical Care
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dopamine,Inapplicable
Therapeutic Area : Neurology
Study Phase : Phase I/ Phase II
Sponsor : InBrain Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Dopaminergic RestauratIon by IntraVEntriculaire Administration
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 02, 2020
Lead Product(s) : Dopamine,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Phase I/ Phase II
Sponsor : InBrain Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dopamine,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Cork University Hospital | Coombe Women and Infants University Hospital | Royal College of Surgeons, Ireland | National Maternity Hospital, Ireland | University Hospital Antwerp | KU Leuven | University of Alberta | CHU Sainte-Justine | Institute for the
Deal Size : Inapplicable
Deal Type : Inapplicable
Management of Hypotension In the Preterm Infant
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 30, 2011
Lead Product(s) : Dopamine,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Cork University Hospital | Coombe Women and Infants University Hospital | Royal College of Surgeons, Ireland | National Maternity Hospital, Ireland | University Hospital Antwerp | KU Leuven | University of Alberta | CHU Sainte-Justine | Institute for the
Deal Size : Inapplicable
Deal Type : Inapplicable